ABBVIE TIBBI ILACLARSAN.VE TIC.LTD.STI.

Company Introduction

AbbVie Tibbi Ilaclar San. Ve Tic. Ltd. Sti. is the Turkish subsidiary of AbbVie Inc., a leading global biopharmaceutical company. This entity is responsible for the commercial operations of AbbVie's innovative pharmaceutical products within Turkey. Its core activities include the marketing, sales, and distribution of a wide range of medicines across various therapeutic areas, such as immunology, oncology, neuroscience, virology, and ophthalmology. The company's mission in Turkey is to provide breakthrough therapies to patients, collaborate with healthcare professionals, and contribute to the advancement of healthcare in the region, adhering to global standards and local regulations. As an integral part of AbbVie's global network, the Turkish office ensures the availability and accessibility of its specialized treatments to the Turkish market.

Classification: Trading Company (Commercial Subsidiary)

Here are some of the products manufactured or marketed by ABBVIE TIBBI ILACLAR SAN. VE TIC. LTD. STI. in Turkey:

* Humira (adalimumab)

* Mavyret (glecaprevir/pibrentasvir)

* Venclyxto (venetoclax)

* Skyrizi (risankizumab)

* Rinvoq (upadacitinib)

* Botox (onabotulinumtoxinA)

* Duodopa (levodopa/carbidopa intestinal gel)